bryan johnson bpc 157 Well said. While Johnson's experience is just a single case (an n=1) and doesn't establish causation the way a randomized controlled trial can, it highlights an important issue Bryan Penn-Johnson - Cal Poly

BPC-157 dosage varies based on the treatment goal, delivery method, cycle length, health history, and provider guidance

The standard AOD 9604 dosage in clinical use is 250500 mcg, administered subcutaneously once every morning on an empty stomach, and cycled in 412-week blocks

It supports angiogenesis, reduces inflammation, and enhances cell migration, differentiation, and cytoskeletal remodeling

Side effects are rare and mild: Mild soreness and bruising at injection site Headache or dizziness (rare) Allergic reactions are extremely rare People with kidney disease or cobalt allergy should seek medical advice from GP before treatment